samedan logo
 
 
spacer
home > pmps > winter 2008 > the future is disposable
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Future is Disposable

Christian Husegaard at Bang & Olufsen Medicom discusses how the market is now evolving towards more user-friendly injection systems, as evidenced by the emergence of next-generation, disposable auto injectors for various treatments

An increasing proportion of pipeline drugs and drug introductions are administered by injection. However, the development of corresponding injection devices has not been able to keep up with the development of these large molecule drug formulations, leaving an increasing number of patients to administer their own treatment by use of unwieldy and complicated devices.

THE GAP

The pharmaceutical biotechnology industry has contributed to the growth in injectable drugs, and is now a major driver in new drugs coming to the market. Despite the progress made in developing new and innovative treatments for a wide range of therapeutic areas, this does not appear to have been matched by the development in drug delivery solutions, creating a ‘quality gap’ between the two elements that should in practice be working together – the drug and the device.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Christian Husegaard is Vice President of Drug Delivery Solutions and Services at B&O Medicom. Having joined in 1995, he was appointed Vice President in 2007. Today Christian is working to develop and bring innovative and robust injection solutions to the market.
spacer
Christian Husegaard
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Partners with Loftware for Adaptive Investigational Product Labeling

Collaboration reinforces Signant's end-to-end clinical supplies management solutions and supports the complex manufacturing and distribution models inherent in modern clinical research
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement